Research Article
Effect of Educational Intervention on Adverse Drug Reporting by Physicians: A Cross-Sectional Study
Table 2
Attitude of the physicians of both groups regarding pharmacovigilance.
| | Doctors attending CME | Doctors not attending CME |
| Main purpose of ADR reporting system | | | Identify safe drugs | 25 | 42** | Measure the incidence of ADRs | 33 | 17* | Identify predisposing factors to ADRs | 26 | 8## | Identify new ADRs | 17 | 22 | Comparison of ADRs within the same class | 8 | 11 | Factors encouraging ADR reporting | | | Seriousness of ADR | 57 | 94# | Unusualness of ADR | 59 | 53 | New drug | 65 | 47** | Correct diagnosis | 12 | 21 | Well-recognised ADR | 24 | 36 | Factors discouraging ADR reporting | | | Reporting may be wrong | 42 | 38 | Lack of time | 45 | 38 | Single unreported case does not affect ADR database | 57 | 33# | Do not know where to report | 37 | 57** | Do not feel the need to report ADR | 19 | 21 | Negative impact on company marketing the drug | — | 3 | Is ADR reporting a professional obligation? | | | Yes | 51 | 61 | No | 13 | 28** | Do not know | 29 | 8* | Perhaps | 7 | 3 | Which ADR should be reported? | | | None | — | 1 | All | 36 | 56** | All serious ADRs | 55 | 39** | ADRs to new drugs | 32 | 11## | Unknown ADRs to old drugs | 7 | 7 | Opinion regarding establishment of ADR reporting centre | | | Should be in all hospitals | 68 | 58 | Not needed in all hospitals | 11 | 8 | One in a city | 10 | 10 | Depend on bed size | 16 | 21 | ADRs reporting should be | | | Compulsory | 48 | 64** | Voluntary | 38 | 15# | Rewarded | 2 | 9 | Hide the identity of prescriber | 6 | 6 | Hide the identity of reporter | 6 | 6 |
|
|
; #; **; ##.
|